Overview
In this study, defined cases of COVID-19 with mild, moderate or severe pneumonia will be treated with standard treatment regimens in combination with oral administration of Colchicine Plus Herbal phenolic monoterpene Fractions. Improvement in clinical, laboratory and radiological manifestations will be evaluated in treated patient compared to control group.
Eligibility
Inclusion Criteria:
- Defined cases of COVID-19 based on laboratory and/or radiological and clinical manifestation
Exclusion Criteria:
- Age <10, Pregnancy, Sever kidney dysfunction, Previous history of allergy to Colchicine, not willing to sign informed consent form